Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2012
05/31/2012US20120135450 Substrates, devices, and methods for quantitative liquid crystal assays
05/31/2012US20120135448 Methods and devices for the fabrication of 3d polymeric fibers
05/31/2012US20120135447 Nucleic acids encoding t2r, a novel family of taste receptors
05/31/2012US20120135446 Microfluidic Device and Related Methods
05/31/2012US20120135445 Cell transport system
05/31/2012US20120135444 Sampling devices and methods of use
05/31/2012US20120135442 Protein crystallization using molecularly imprinted polymers
05/31/2012US20120135441 Enzymes and methods for resolving amino vinyl cyclopropane carboxylic acid derivatives
05/31/2012US20120135440 Cationic anti-microbial peptides and methods of use thereof
05/31/2012US20120135439 Method for production of accumulated product of nano-substance, accumulated product of nano-substance, device comprising the accumulated product, and method for analysis of structure of nano-substance
05/31/2012US20120135438 Detecting a microorganism strain in a liquid sample
05/31/2012US20120135437 Biosensors utilizing ink jet-printed biomolecule compatible sol gel inks and uses thereof
05/31/2012US20120135436 Method of Determining Enzymatic Activity in Biological Media
05/31/2012US20120135435 Methods for Identifying Factors That Control the Folding of Amyloid Proteins of Diverse Origin
05/31/2012US20120135426 Method for quantifying phosphokinase activity on proteins
05/31/2012US20120135424 Mer diagnostic and therapeutic agents
05/31/2012US20120135419 Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic Leukemia and Oligonucleotides for Use in this Method
05/31/2012US20120135418 Automatic Detection Kit for Detecting HLA Alleles Using Real-Time Polymerase Chain Reaction
05/31/2012US20120135417 Methods for screening and identifying compounds
05/31/2012US20120135416 Compositions And Methods For Treating And Diagnosing Pancreatic Cancer
05/31/2012US20120135415 Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
05/31/2012US20120135414 Chemically-enhanced primer compositions, methods and kits
05/31/2012US20120135413 Compositions for use in security marking
05/31/2012US20120135412 Quality control bioassays for nutriceutical and medicinal products
05/31/2012US20120135411 Pyrococcus furiosus strains and methods of using same
05/31/2012US20120135409 Methods of monitoring conditions by sequence analysis
05/31/2012US20120135408 Unc-45a splice variants based cancer diagnostics and therapeutics
05/31/2012US20120135407 Compositions and Methods for Intramolecular Nucleic Acid Rearrangement
05/31/2012US20120135406 Method for determining lymph node metastasis in cancer or risk thereof and rapid determination kit for the same
05/31/2012US20120135403 Fibrosis susceptibility gene and uses thereof
05/31/2012US20120135402 Gene sequence variances in genes related to folate metabolism having utility in determining the treatment of disease
05/31/2012US20120135401 Methods and Compounds for the Diagnosis of Inflammatory Disease and Identification of Pharmacological Agents Useful in the Treatment of Inflammatory Disease
05/31/2012US20120135400 Novel Fluorescent and Colored Proteins, and Polynucleotides that Encode These Proteins
05/31/2012US20120135399 Cancer biomarker and methods of using thereof
05/31/2012US20120135398 Method of Detection and Related Detection Device
05/31/2012US20120135397 Human immunodeficiency virus type 1 (hiv-1) detection method and kit therefor
05/31/2012US20120135395 Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Anti-HIV Drugs
05/31/2012US20120135394 Apparatus for integrated real-time nucleic acid analysis, and method for detecting a target nucleic acid using same
05/31/2012US20120135393 Real-time pcr point mutation assays for detecting hiv-1 resistance to antiviral drugs
05/31/2012US20120135092 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
05/31/2012US20120135024 Neisseria meningitidis antigens and compositions
05/31/2012US20120135019 Fviii peptides for immune tolerance induction and immunodiagnostics
05/31/2012US20120135015 Induction of Pancreatic Stem Cells by Transient Overexpression of Reprogramming Factors and PDX1 Selection
05/31/2012US20120135014 Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
05/31/2012US20120135000 Methods and compositions for treating ocular disorders
05/31/2012US20120134985 Methods for modulating metabolic and circadian rhythms
05/31/2012US20120134983 Method for Identifying Interventions that Control the Translational Activity of Ribosomal Proteins in Different MRNA Expression
05/31/2012US20120134972 Novel Polypeptides Having Endolysin Activity And Uses Thereof
05/31/2012US20120134969 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/31/2012US20120134957 Latent phase viral interleukin-10-(vii-10) and uses thereof
05/31/2012US20120134928 Modulation of terminase activity at telomeres and dna double-strand breaks
05/31/2012US20120134926 Charge-dynamic polymers and delivery of anionic compounds
05/31/2012US20120134877 Methods for neutralizing anthrax or anthrax spores
05/31/2012US20120132527 Use of microfluidic systems in the electrochemical detection of target analytes
05/31/2012CA2818890A1 Method and system for prognosis and treatment of diseases using portfolio of genes
05/31/2012CA2818887A1 Diagnostic and/or screening agents and uses therefor
05/31/2012CA2818824A1 Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
05/31/2012CA2818577A1 Methods and kits for differential staining of abnormal urinary system cells
05/31/2012CA2818556A1 Nucleotide-based probes and methods for the detection and quantification of macromolecules and other analytes
05/31/2012CA2818390A1 Sorting of adherent cells by selective transformation of labels
05/31/2012CA2818169A1 High-throughput, sensitive detection of glucose-6-phosphate dehydrogenase
05/31/2012CA2817183A1 Methods for detecting low grade inflammation
05/31/2012CA2817135A1 Device for detecting a fungal contamination
05/31/2012CA2801370A1 Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
05/30/2012EP2458517A1 Early detection of sepsis
05/30/2012EP2458384A2 Method for diagnosing the presence and/or severity of a hepatic pathology in a patient and/or for monitoring the effectiveness of treating such a pathology
05/30/2012EP2458019A2 Methods and compositions for determining resistance of HIV-1 to protease inhibitors
05/30/2012EP2458018A2 Methods and compositions for determining resistance of HIV-1 to protease inhibitors
05/30/2012EP2458017A1 Markers For Breast Cancer
05/30/2012EP2458016A1 Methods and probe combinations for detecting melanoma
05/30/2012EP2458015A1 Method for providing DNA fragments derived from an archived sample
05/30/2012EP2458014A1 Prognostic markers for acute myeloid leukemia (AML)
05/30/2012EP2458011A1 Compositions, methods, and kits for amplifying nucleic acids
05/30/2012EP2458002A1 Method and kit for detection of microorganism
05/30/2012EP2457989A1 Image processing device, culture observation apparatus, and image processing method
05/30/2012EP2457922A1 Altered FAD2 and FAD3 genes in brassica and the molecular marker-assisted detection thereof
05/30/2012EP2457584A1 Myxoma virus mutants for cancer treatment
05/30/2012EP2457099A1 Apparatus for bio-automation
05/30/2012EP2457095A1 Parp and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer
05/30/2012EP2457090A2 Flow cell device
05/30/2012EP2456895A1 Oligonucleotides for detecting chicken astrovirus
05/30/2012EP2456894A1 Sorghum centromere sequences and minichromosomes
05/30/2012EP2456893A1 Sugarcane centromere sequences and minichromosomes
05/30/2012EP2456892A2 Method for sequencing a polynucleotide template
05/30/2012EP2456891A1 Universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
05/30/2012EP2456890A1 Gene expression markers for crohn's disease
05/30/2012EP2456889A2 Markers for endometrial cancer
05/30/2012EP2456888A1 Probes for specific analysis of nucleic acids
05/30/2012EP2456887A2 Methods and compositions for quantitative detection of nucleic acid sequences over an extended dynamic range
05/30/2012EP2456886A1 A method of removing nucleic acid contamination in reverse transcription and amplification reactions
05/30/2012EP2456885A2 Methods for assessing disease risk
05/30/2012EP2456884A1 Sequences and their use for detection and characterization of e. coli o157:h7
05/30/2012EP2456883A1 Label free methods related to phosphodiesterases
05/30/2012EP2456882A1 Biological sterilization indicator and method of using same
05/30/2012EP2456881A2 Method and apparatus for performing cytometry
05/30/2012EP2456875A1 Plastid transit peptides derived from lower photosynthetic eukaryotes and methods
05/30/2012EP2456864A1 Synthetic oplophorus luciferases with enhanced light output
05/30/2012EP2099934B1 Detection and quantification of biomolecules using mass spectrometry
05/30/2012EP2059805B1 Microbe-sensitive indicators and use of the same
05/30/2012EP1945797B1 Hepatitis c virus ns2/3 activity assay
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 3003